1 citations
,
April 2022 in “Dermatologic Surgery”
This article introduces the Progressive Loss (PL) Scale, aimed at helping physicians communicate the long-term cosmetic risks of hair restoration surgery to patients.
This study validated the Black Identity, Hair Product Use, and Breast Cancer Scale (BHBS) as a tool to measure social and cultural factors related to hair product use and perceived breast cancer risk in Black women.
This study found that a genetic test using 5 to 20 SNPs can predict male pattern baldness with variable accuracy in European men, especially those aged 50 and older.
This research review discusses the potential link between androgenetic alopecia and increased cardiovascular risk but does not report any new experimental findings.
28 citations
,
October 2018 in “Clinical Obstetrics and Gynecology”
This study suggests that gender-affirming testosterone therapy in transgender men is generally safe and effective with adequate screening and monitoring, although high-quality long-term studies are lacking.
Finasteride may affect male offspring's fertility and hormonal balance, with debates on whether to discontinue use before conception. Some users report no issues, while others highlight the high doses used in rat studies.
A permanent hair loss solution could involve reprogramming hair follicles to resist DHT using mRNA and siRNA. However, high costs, safety concerns, and the pharmaceutical industry's preference for ongoing treatments over one-time cures are major obstacles, with finasteride and minoxidil remaining standard treatments.
The user experienced significant hair regrowth after six months of using oral Finasteride (1mg) and Minoxidil (2.5mg) nightly, with no side effects. They also used dermastamping and biotin, emphasizing consistency and a healthy lifestyle.